Clinical Trials Browser

Withdrawn × cixutumumab × CNS × Clear all

NCT01182883 2017-07-02

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Phase 1 Withdrawn

Glioma, Pinealoma, Brain Stem Neoplasms